Prescribing GLP-1s: What to know about liability exposure and risk mitigation
Jeanne Varner Powell, JD

Learning objectives:

• Evaluate at least 3 areas of liability exposure for physicians prescribing GLP-1s.
• Assess and implement at least 3 strategies to reduce medical professional liability risk when prescribing GLP-1s.
• Demonstrate a basic understanding of what types of claims are presently being asserted in GLP-1 lawsuits.

Ms. Varner Powell has no disclosures. 

Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

The AOMA designates this activity for a maximum of 1.0 hours of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AOMA designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOMA Grievance Policy: The Arizona Osteopathic Medical Association strives to provide continuing medical education programs that fulfill the needs of attendees and meet the requirements of AOA Accreditation and ACCME Accreditation. Comments, questions, or complaints should be submitted in writing to Teresa Roland, Director of Education, by mail to AOMA, 3039 W. Peoria Ave, Suite C102-158, Phoenix, AZ 85029, or email teresa@azosteo.org.